BR9916107A - Processo para manufaturamento de formulação de beta-bloqueadores tópicos com eficiência aperfeiçoada - Google Patents
Processo para manufaturamento de formulação de beta-bloqueadores tópicos com eficiência aperfeiçoadaInfo
- Publication number
- BR9916107A BR9916107A BR9916107-9A BR9916107A BR9916107A BR 9916107 A BR9916107 A BR 9916107A BR 9916107 A BR9916107 A BR 9916107A BR 9916107 A BR9916107 A BR 9916107A
- Authority
- BR
- Brazil
- Prior art keywords
- formulation
- timolol
- efficiency
- beta
- manufacturing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Patente de Invenção para "PROCESSO PARA MANUFATURAMENTO DE FORMULAçãO DE BETA-BLOQUEADORES TóPICOS COM EFICIêNCIA APERFEIçOADA". Beta-bloqueadores são usados como preparações oftámicas tópicas para redução da pressão intra-ocular. O beta-bloqueador usado para esta proposta inclui timolol, levobunolol, carteolol, metipranalol. Eles reduzem a produção aquosa e, desse modo, reduz o I O P. Eles são comumente usados como gótas. A eficiência dos beta-bloqueadores é dependente da concentração de droga na formulação. Contudo, aumentando-se a concentração de droga além das formas de dosagem aprovadas, não se aumenta a eficiência significantemente, por exemplo. O timolol 0,5% tem capacidade de abaixamento de pressão idêntica ao timolol 1%. As tentativas de aperfeiçoar a eficiência de redução de pressão dos beta-bloqueadores não têm sido bem sucedidas. A formulação liberada de timolol (Timolol XE) tem resultado em quantidade de droga para alcançar o mesmo efeito terapêutico. Contudo, nenhuma das formulações tem eficiência aperfeiçoada de droga para redução de I O P. A presente invenção se refere ao processo de manufaturamento de tal formulação de beta-bloqueadores que aperfeiçoa seu efeito de abaixamento de I O P. A formulação assim preparada é não-irradiante e bem tolerada. O processo de manufaturamento de nova formulação com eficiência aperfeiçoada, envolve o uso de carboprolol e preservativo. O gel de timolol 0,5% formulado usando o processo foi avaliado em normal, bem como em olhos com glaucomas. A redução de I O P é encontrada ser aproximadamente 15% maior do que encontrado em drogas em indivíduos normais. Achados similares são também observados em olhos com glaucomas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LK1157898 | 1998-12-11 | ||
| PCT/IB1999/000378 WO2000035439A1 (en) | 1998-12-11 | 1999-03-04 | The process for manufacturing formulation of topical beta blockers with improved efficacy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9916107A true BR9916107A (pt) | 2002-04-30 |
Family
ID=19720977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9916107-9A BR9916107A (pt) | 1998-12-11 | 1999-03-04 | Processo para manufaturamento de formulação de beta-bloqueadores tópicos com eficiência aperfeiçoada |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1137407B1 (pt) |
| AP (1) | AP2001002206A0 (pt) |
| AU (1) | AU770365B2 (pt) |
| BR (1) | BR9916107A (pt) |
| CA (1) | CA2354765A1 (pt) |
| DK (1) | DK1137407T3 (pt) |
| EA (1) | EA004050B1 (pt) |
| IL (1) | IL143687A0 (pt) |
| RU (1) | RU2218156C2 (pt) |
| WO (1) | WO2000035439A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008055205A2 (en) * | 2006-10-31 | 2008-05-08 | Alcon Research, Ltd. | Pai-1 binding modulators for the treatment of ocular disorders |
| CN104189906A (zh) | 2007-01-29 | 2014-12-10 | V生命科学技术有限公司 | 用于治疗糖尿病并发症的药用组合物 |
| EP4126076A1 (en) | 2020-03-31 | 2023-02-08 | Sentiss Pharma Private Limited | A sterilization process of timolol gel forming solution through aseptic filtration |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2588189B1 (fr) * | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| IE62871B1 (en) * | 1988-03-08 | 1995-03-08 | Warner Lambert Co | Compositions with enhanced penetration |
| JPH0773394B2 (ja) * | 1988-03-09 | 1995-08-02 | 富士通株式会社 | 異種通信網の一元的通信網への統合方法 |
| EP0582321A1 (de) * | 1992-01-17 | 1994-02-09 | Gramer, Eugen, Prof.Dr.med.Dr.jur. | Kombinationspräparat auf der Basis von Dipivalylepinephrin (DPE) und Betablocker zur Augeninnendrucksenkung |
-
1999
- 1999-03-04 EA EA200100655A patent/EA004050B1/ru not_active IP Right Cessation
- 1999-03-04 WO PCT/IB1999/000378 patent/WO2000035439A1/en active IP Right Grant
- 1999-03-04 EP EP99905124A patent/EP1137407B1/en not_active Expired - Lifetime
- 1999-03-04 DK DK99905124T patent/DK1137407T3/da active
- 1999-03-04 RU RU2001119268/14A patent/RU2218156C2/ru not_active IP Right Cessation
- 1999-03-04 CA CA002354765A patent/CA2354765A1/en not_active Abandoned
- 1999-03-04 IL IL14368799A patent/IL143687A0/xx unknown
- 1999-03-04 BR BR9916107-9A patent/BR9916107A/pt not_active IP Right Cessation
- 1999-03-04 AP APAP/P/2001/002206A patent/AP2001002206A0/en unknown
- 1999-03-04 AU AU25411/99A patent/AU770365B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2354765A1 (en) | 2000-06-22 |
| EA200100655A1 (ru) | 2002-04-25 |
| EA004050B1 (ru) | 2003-12-25 |
| AP2001002206A0 (en) | 2001-09-30 |
| EP1137407B1 (en) | 2004-02-18 |
| EP1137407A1 (en) | 2001-10-04 |
| AU770365B2 (en) | 2004-02-19 |
| IL143687A0 (en) | 2002-04-21 |
| DK1137407T3 (da) | 2004-05-10 |
| WO2000035439A1 (en) | 2000-06-22 |
| AU2541199A (en) | 2000-07-03 |
| RU2218156C2 (ru) | 2003-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4976969A (en) | Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex | |
| RU2477631C2 (ru) | Водные фармацевтические композиции, содержащие борат-полиольные комплексы | |
| US5414011A (en) | Preservative system for ophthalmic formulations | |
| US5945121A (en) | Liposome eye drops | |
| CA2181048C (en) | A method for sustained and extended corneal analgesia | |
| JP5673531B2 (ja) | 眼科用組成物 | |
| EP2598119B1 (en) | Preservative free brimonidine and timolol solutions | |
| KR920001461B1 (ko) | 안과 액제의 제조방법 | |
| US6147081A (en) | Ophthalmic solution | |
| GB2078515A (en) | Topical anti-viral preparation | |
| RU2004111984A (ru) | Способ лечения инфекций среднего уха | |
| ES2708451T3 (es) | Soluciones de bimatoprost y timolol sin conservantes | |
| JP2021102626A5 (pt) | ||
| JP2002097129A (ja) | 点眼剤 | |
| JP3175742B1 (ja) | コンタクトレンズ用眼科用組成物 | |
| BR9916107A (pt) | Processo para manufaturamento de formulação de beta-bloqueadores tópicos com eficiência aperfeiçoada | |
| AU7099194A (en) | Methods and compositions for lowering intraocular pressure | |
| WO2020140365A1 (zh) | 一种含有黄原胶的保湿润滑组合物及其应用 | |
| BR0209601A (pt) | Método para o tratamento da hipertensão ocular e do glaucoma | |
| JP2009161456A (ja) | 眼科用組成物 | |
| WO1998035676B1 (en) | A medicament against infertility and for increasing fertility | |
| EP2604298B1 (en) | Multipurpose solutions for contact lens care comprising chamomile | |
| EP2014333A1 (en) | Use of cooling agents for treatment or prevention of lacrimation or eye burning | |
| CN113546013A (zh) | 一种眼部护理喷液制备方法及其应用 | |
| EP0589020A4 (en) | Verapamil hcl formulation and other ophthalmic solutions with buffer system for ocular administration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5O, 6O, 7O E 8O ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007. |